Oak Hill Wealth Advisors LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 4.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,727 shares of the healthcare conglomerate’s stock after buying an additional 105 shares during the quarter. Oak Hill Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $1,428,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $30,000. Finally, Promus Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $32,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
UNH has been the topic of a number of research reports. Robert W. Baird downgraded UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price objective on the stock. in a report on Wednesday, June 11th. TD Cowen lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price for the company. in a research note on Monday, May 19th. UBS Group lowered their target price on UnitedHealth Group from $400.00 to $385.00 and set a “buy” rating for the company in a research note on Wednesday. Erste Group Bank lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 30th. Finally, KeyCorp lowered their target price on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating for the company in a research note on Monday, June 2nd. One research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $415.57.
UnitedHealth Group Price Performance
Shares of UNH opened at $302.19 on Thursday. The firm has a market cap of $274.13 billion, a price-to-earnings ratio of 12.65, a PEG ratio of 1.45 and a beta of 0.44. The stock has a 50 day moving average of $342.22 and a 200-day moving average of $458.07. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter in the previous year, the business posted $6.91 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a $2.21 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.93%. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.
Insider Buying and Selling
In other UnitedHealth Group news, Director John H. Noseworthy purchased 300 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The stock was bought at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the transaction, the director now owns 6,063 shares of the company’s stock, valued at $1,892,626.08. The trade was a 5.21% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO John F. Rex bought 17,175 shares of the firm’s stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- ETF Screener: Uses and Step-by-Step Guide
- Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom
- What is an Earnings Surprise?
- Uber and Tesla Surge on Robotaxis, Analyst Touts Texas Rides
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.